Clinical Trial

TMS for PTSD in Youth

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-07
Trial Details
NCT Number NCT07401225
Lead Sponsor The University of Texas Health Science Center at San Antonio
Collaborators: Texas Child Mental Health Care Consortium: TCMHCC
Conditions Post Traumatic Stress Disorder (PTSD)
Enrollment 20 participants
Start Date 2026-05-09
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-13